These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 25971781)

  • 41. Pakistan's low contraceptive use tied to medical issues.
    Hardee K
    Netw Res Triangle Park N C; 1993 Mar; 13(3):24-6. PubMed ID: 12318098
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Roles of the pharmacist in the use of safe and highly effective long-acting reversible contraception: an opinion of the women's health practice and research network of the American College of Clinical Pharmacy.
    Rafie S; McIntosh J; Shealy KM; Borgelt LM; Forinash A; Shrader SP; Koepf ER; McClendon KS; Griffin BL; Horlen C; Karaoui LR; Rowe EL; Lodise NM; Wigle PR
    Pharmacotherapy; 2014 Sep; 34(9):991-9. PubMed ID: 24989020
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Strengthening contraceptive counselling services to empower clients and meet their needs: protocol for a two-stage, multiphase complex intervention in Pakistan and Nigeria.
    Tran NT; Ali M; Azmat SK; Seuc A; Olaolorun FM; Awan MA; Morhason-Bello I; Thom EM; Martin J; Abubakar HD; Uzma Q; Kiarie J
    BMJ Open; 2024 Jun; 14(6):e081967. PubMed ID: 38839392
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Discontinuation of long-acting reversible contraceptive methods and associated factors among reproductive-age women in Shashemene town, Oromia, Ethiopia.
    Letose F; Tusa A; Sahlu D; Miherite Y
    Front Glob Womens Health; 2024; 5():1269302. PubMed ID: 38774251
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Factors associated with the discontinuation of modern methods of contraception in the low income areas of Sukh Initiative Karachi: A community-based case control study.
    Thobani R; Jessani S; Azam I; Reza S; Sami N; Rozi S; Abrejo F; Saleem S
    PLoS One; 2019; 14(7):e0218952. PubMed ID: 31269086
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Retrospective analysis of the impact of increasing access to long acting reversible contraceptives in a commercially insured population.
    Law A; Pilon D; Lynen R; Laliberté F; Gozalo L; Lefebvre P; Duh MS
    Reprod Health; 2016 Aug; 13(1):96. PubMed ID: 27549429
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Contraceptive use among adolescent and young women in North and South Kivu, Democratic Republic of the Congo: A cross-sectional population-based survey.
    Casey SE; Gallagher MC; Kakesa J; Kalyanpur A; Muselemu JB; Rafanoharana RV; Spilotros N
    PLoS Med; 2020 Mar; 17(3):e1003086. PubMed ID: 32231356
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Attendance of an Initial Follow-up Visit after Long-Acting Reversible Contraception Insertion and Method Continuation Among Adolescents and Young Adults: A Retrospective Study.
    Bryson AE; Cabral HJ; Coles MS
    J Pediatr Adolesc Gynecol; 2021 Aug; 34(4):525-529. PubMed ID: 33486086
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Follow-Up Care and 6-Month Continuation Rates for Long-Acting Reversible Contraceptives in Adolescents and Young Adults: A Retrospective Chart Review.
    Jones AE; Kaul S; Harding J; Weldon DLM; Akers AY
    J Pediatr Adolesc Gynecol; 2020 Feb; 33(1):39-44. PubMed ID: 31513921
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Introducing Long-Acting Contraceptive Removal Indicators in a Pilot Study in Mozambique: Dynamics of Discontinuation and Implications for Quality of Care.
    Jacinto A; Ronda AV; Lee C; Fikree FF; Ramirez-Ferrero E
    Glob Health Sci Pract; 2022 Feb; 10(1):. PubMed ID: 35040804
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dual method use among long-acting reversible contraceptive users.
    Bernard C; Zhao Q; Peipert JF
    Eur J Contracept Reprod Health Care; 2018 Apr; 23(2):97-104. PubMed ID: 29582687
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Continuation rates of long-acting methods of contraception. A comparative study of Norplant implants and intrauterine devices.
    Fleming D; Davie J; Glasier A
    Contraception; 1998 Jan; 57(1):19-21. PubMed ID: 9554246
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-Acting Reversible Contraceptives for Incarcerated Women: Feasibility and Safety of On-Site Provision.
    Sufrin C; Oxnard T; Goldenson J; Simonson K; Jackson A
    Perspect Sex Reprod Health; 2015 Dec; 47(4):203-11. PubMed ID: 26484795
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A comparison of Norinyl and Brevicon in three sites in Sri Lanka.
    Basnayake S; de Silva SV; Miller PC; Rogers S
    Contraception; 1983 May; 27(5):453-64. PubMed ID: 6884024
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Postabortion Contraceptive Use and Continuation When Long-Acting Reversible Contraception Is Free.
    Goyal V; Canfield C; Aiken ARA; Dermish A; Potter JE
    Obstet Gynecol; 2017 Apr; 129(4):655-662. PubMed ID: 28277358
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cost-benefit analysis of enhancing the uptake of long-acting reversible contraception in Australia.
    Concepcion K; Lacey S; McGeechan K; Estoesta J; Bateson D; Botfield J
    Aust Health Rev; 2020 Jun; 44(3):385-391. PubMed ID: 31655632
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-Acting Reversible Contraception Uptake and Associated Factors among Women of Reproductive Age in Rural Kenya.
    Ontiri S; Ndirangu G; Kabue M; Biesma R; Stekelenburg J; Ouma C
    Int J Environ Res Public Health; 2019 May; 16(9):. PubMed ID: 31052372
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Postpartum contraception: initiation and effectiveness in a large universal healthcare system.
    Brunson MR; Klein DA; Olsen CH; Weir LF; Roberts TA
    Am J Obstet Gynecol; 2017 Jul; 217(1):55.e1-55.e9. PubMed ID: 28257962
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of staff training and cost support on provision of long-acting reversible contraception in community health centers.
    Buckel C; Maddipati R; Goodman M; Peipert JF; Madden T
    Contraception; 2019 Apr; 99(4):222-227. PubMed ID: 30685287
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluating the impact of Marie Stopes International's digital family planning counselling application on the uptake of long-acting and permanent methods of contraception in Vietnam and Ethiopia: a study protocol for a multi-country cluster randomised controlled trial.
    Bates LA; Hicks JP; Walley J; Robinson E
    Trials; 2018 Aug; 19(1):420. PubMed ID: 30075739
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.